Education
About Us
Working with TipRanks
Follow Us
Algernon Pharmaceuticals (AGNPF)
OTHER OTC:AGNPF
RESEARCH TOOLSreports
| Sep 24 | Sep 23 | Sep 22 | Sep 21 | Sep 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 |
| Gross Profit | C$ -26.56K | C$ -50.40K | C$ -34.94K | C$ 0.00 | C$ 0.00 |
| Operating Income | C$ -2.41M | C$ -5.02M | C$ -6.06M | C$ -8.05M | C$ -8.76M |
| EBITDA | C$ -476.42K | C$ -4.98M | C$ -6.02M | C$ 0.00 | C$ -8.54M |
| Net Income | C$ -502.98K | C$ -6.78M | C$ -6.05M | C$ -7.72M | C$ -8.42M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | C$ 596.20K | C$ 125.08K | C$ 1.41M | C$ 2.41M | C$ 6.12M |
| Total Assets | C$ 3.94M | C$ 4.19M | C$ 8.14M | C$ 10.14M | C$ 12.82M |
| Total Debt | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 |
| Net Debt | C$ -596.20K | C$ -125.08K | C$ -1.41M | C$ -2.41M | C$ -6.12M |
| Total Liabilities | C$ 1.78M | C$ 2.72M | C$ 2.52M | C$ 1.02M | C$ 607.05K |
| Stockholders' Equity | C$ 2.17M | C$ 1.47M | C$ 5.62M | C$ 9.12M | C$ 12.22M |
| Cash Flow | |||||
| Free Cash Flow | C$ -2.79M | C$ -2.61M | C$ -3.06M | C$ -7.95M | C$ -6.71M |
| Operating Cash Flow | C$ -2.71M | C$ -2.55M | C$ -2.91M | C$ -7.82M | C$ -6.61M |
| Investing Cash Flow | C$ 2.28M | C$ -59.50K | C$ -144.61K | C$ -124.45K | C$ -99.74K |
| Financing Cash Flow | C$ 901.09K | C$ 1.33M | C$ 2.06M | C$ 4.25M | C$ 12.62M |